Miller, Ian
for the GWPCARE6 Study Group
5 papers on CoChatORCID 0000-0003-0416-1015
Most cited papers
- Verified
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Devinsky, O., Cross, J. H., Laux, L., Marsh, E., Miller, I., Nabbout, R., Scheffer, I. E., Thiele, E. A., & Wright, S. (2017) · New England Journal of Medicine
Epilepsy research and treatmentCannabis and Cannabinoid Research
Cited by 1,711
- Verified
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
Devinsky, O., Marsh, E., Friedman, D., Thiele, E., Laux, L., Sullivan, J., Miller, I., Flamini, R., Wilfong, A., Filloux, F., et al. (2016) · The Lancet Neurology
Epilepsy research and treatmentCannabis and Cannabinoid Research
Cited by 900
- Verified
Nine-year prospective efficacy and safety of brain-responsive neurostimulation for focal epilepsy
Nair, D. R., Laxer, K. D., Weber, P. B., Murro, A. M., Park, Y. D., Barkley, G. L., Smith, B. J., Gwinn, R. P., Doherty, M. J., Noe, K. H., et al. (2020) · Neurology
Epilepsy research and treatmentVagus Nerve Stimulation Research
Cited by 490
- Verified
Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial
Lagae, L., Sullivan, J., Knupp, K., Laux, L., Polster, T., Nikanorova, M., Devinsky, O., Cross, J. H., Guerrini, R., Talwar, D., et al. (2019) · The Lancet
Epilepsy research and treatmentPharmacological Effects and Toxicity Studies
Cited by 384
- Verified
Add-on Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis Complex: A Placebo-Controlled Randomized Clinical Trial
Thiele, E. A., Bebin, E. M., Bhathal, H., Jansen, F. E., Kotulska, K., Lawson, J. A., O'Callaghan, F. J., Wong, M., Sahebkar, F., Checketts, D., et al. (2021) · JAMA Neurology
Epilepsy research and treatmentCannabis and Cannabinoid Research
Cited by 281
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free